Mglur4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
mGluR4 (Metabotropic Glutamate Receptor 4) is a member of the Group I metabotropic glutamate receptor family that plays crucial roles in synaptic transmission and neuronal excitability[^1]. As a presynaptic autoreceptor, mGluR4 modulates glutamate release and regulates synaptic plasticity at excitatory synapses[^2]. It is highly expressed in the basal ganglia, making it a significant therapeutic target for Parkinson's disease and other movement disorders[^3].
mGluR4 belongs to the class C GPCR family, characterized by a large extracellular Venus flytrap domain that binds glutamate, a cysteine-rich domain for transmembrane coupling, and a 7-transmembrane domain for G protein signaling[^4]. Unlike ionotropic glutamate receptors (AMPA, NMDA, kainate), mGluR4 signals through G proteins to modulate ion channel activity and intracellular second messenger systems.
| Protein Name | Metabotropic Glutamate Receptor 4 |
| Gene | GRM4 |
| UniProt ID | Q14833 |
| PDB Structure | 6dwz |
| Molecular Weight | ~103 kDa |
| Subcellular Localization | Presynaptic terminals, postsynaptic membranes |
| Protein Family | Class C G-protein coupled receptor family |
mGluR4 (Metabotropic Glutamate Receptor 4) is a class C G-protein coupled receptor that functions as a presynaptic modulator of glutamatergic transmission[^1]. It is highly expressed in the basal ganglia, particularly in the striatum and substantia nigra, where it plays critical roles in motor control and reward processing[^2]. mGluR4 is unique among group III mGluRs due to its high affinity for glutamate and its ability to modulate dopamine release, making it a compelling therapeutic target for Parkinson's disease[^3].
mGluR4 is a class C GPCR with distinct features:
mGluR4 is a presynaptic modulator:
The study of Mglur4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.